Join to view full profile
2002 Holcombe BlvdDept Of Hematology & Oncology Va 111 HHouston, TX 77030
Phone+1 713-794-7111
Fax+1 713-794-7733
Dr. Sada is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011- Baylor College of MedicineResidency, Internal Medicine, 2005 - 2008
University of Rochester School of Medicine and DentistryClass of 2005
Certifications & Licensure
TX State Medical License 2011 - 2027
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Meclizine for Hepatocellular Carcinoma Start of enrollment: 2017 Oct 13
Publications & Presentations
PubMed
- Nonexposed Endoscopic Full Thickness Resection of Residual Disease After Definitive Chemoradiation for Locally Advanced Gastric Cancer.Brennan W Gioe, Bryan C Luu, Michael M Ittmann, George Chen, Yvonne H Sada
ACG Case Reports Journal. 2025-10-01 - 2 citationsA Multi-Institutional Natural Language Processing Pipeline to Extract Performance Status From Electronic Health Records.Arash Maghsoudi, Yvonne H Sada, Sara Nowakowski, Danielle Guffey, Huili Zhu
Cancer Control. 2024-09-02 - 10 citationsHarnessing physical activity monitoring and digital biomarkers of frailty from pendant based wearables to predict chemotherapy resilience in veterans with cancer.Gozde Cay, Yvonne H Sada, Mohammad Dehghan Rouzi, Md Moin Uddin Atique, Naima Rodriguez
Scientific Reports. 2024-01-31
Press Mentions
Resilient Cancer Patient Grateful for Houston VAMarch 20th, 2023- A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal CancerApril 4th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
